metricas

Radiología (English Edition)

Suggestions
Radiología (English Edition) Usefulness of dynamic contrast-enhanced magnetic resonance imaging in characteri...
Journal Information
Vol. 64. Issue 2.
Pages 101-192 (March - April 2022)
Cite
Cite
Share
Download PDF
More article options
Visits
3314
Vol. 64. Issue 2.
Pages 101-192 (March - April 2022)
Original articles

Usefulness of dynamic contrast-enhanced magnetic resonance imaging in characterizing ovarian tumors classified as indeterminate at ultrasonography

Utilidad de la resonancia magnética dinámica con contraste para caracterizar tumores ováricos ecográficamente indeterminados
Visits
3314
S. Amado Cabana
Corresponding author
sara.amado.cabana@sergas.es

Corresponding author.
, J.C. Gallego Ojea, M. Félez Carballada
Servicio de Radiodiagnóstico, Complexo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract
Objectives

To determine whether there is a significant relationship between the shape of the time-intensity curve on dynamic gadolinium-enhanced magnetic resonance imaging (MRI) of ovarian tumours classified as indeterminate at ultrasonography and the type of lesion (benign, borderline, or malignant) to enable an accurate presurgical diagnosis.

Material and methods

We used dynamic contrast-enhanced MRI to study 68 ovarian tumours that were classified as indeterminate at ultrasonography. We included only cases for which a definitive diagnosis (histologic diagnosis or ≥1 year stability on imaging tests) was available. Each case was classified as benign, borderline, or malignant.

To analyse the MRI studies, we marked regions of interest in the lesion and in the myometrium (as a reference). We obtained a curve defined by the relation between the intensity of enhancement and time and classified each tumour according to four predefined curve types. We also analysed semiquantitative parameters. Finally, we compared the results for each of the three groups of tumours.

Results

We found significant associations (P<.001) between the curves without early enhancement and benign and borderline lesions as well as between the curves with early enhancement and malignant lesions. Malignant lesions were significantly associated with the semiquantitative enhancement parameters: maximum (P=.002), maximum relative (P=.006), and relative (P=.018).

Conclusions

In ovarian tumours classified as indeterminate at ultrasonography, dynamic contrast-enhanced MRI can be useful for classification as benign, borderline, or malignant because the malignant lesions are significantly associated with early enhancement curves.

Keywords:
Magnetic resonance imaging
Contrast media
Image enhancement
Ovarian tumors
Differential diagnosis
Resumen
Objetivos

Determinar si existe una relación significativa entre la morfología de la curva intensidad-tiempo del estudio de resonancia magnética (RM) dinámica con gadolinio de los tumores ováricos ecográficamente indeterminados y el tipo de lesión (benigna, borderline o maligna), para poder realizar un diagnóstico prequirúrgico correcto.

Material y métodos

Se analizaron 68 tumoraciones ováricas ecográficamente indeterminadas, valoradas mediante RM con secuencia dinámica. Únicamente se incluyeron los casos con diagnóstico histológico o con estabilidad en pruebas de imagen tras al menos un año de seguimiento. Cada caso se clasificó en benigno, borderline o maligno.

Para su análisis, se marcaron regiones de interés en la lesión y en el miometrio (como referencia). Se obtuvo una curva definida por la relación entre la intensidad del realce y el tiempo, cuya morfología permitió clasificar cada tumour dentro de uno de los cuatro tipos de curva predefinidos. También se analizaron parámetros semicuantitativos. Finalmente, se compararon los resultados de cada uno de los tres grupos de tumores.

Resultados

Se demostró una relación significativa (P<,001) entre las curvas sin realce precoz con las lesiones benignas y borderline, y entre las malignas con curvas con realce precoz. Las lesiones malignas se asociaron de forma significativa con los parámetros semicuantitativos de realce: máximo (P=,002), relativo máximo (P=,006) y relativo (P=,018).

Conclusiones

En tumores ováricos ecográficamente indeterminados, la RM dinámica con contraste puede ser útil a la hora de clasificarlos como benignos, borderline o malignos, al mostrar las neoplasias malignas una asociación estadísticamente significativa con curvas con realce precoz.

Palabras clave:
Resonancia magnética
Medios de contraste
Realce de imagen
Neoplasias de ovario
Diagnóstico diferencial

Article

These are the options to access the full texts of the publication Radiología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal.
Global cancer statistics, 2012.
CA Cancer J Clin, 65 (2015), pp. 87-108
[2]
C. La Vecchia.
Ovarian cancer: epidemiology and risk factors.
Eur J Cancer Prev, 26 (2017), pp. 55-62
[3]
A.N. Priest, A.B. Gill, M. Kataoka, M.A. McLean, I. Joubert, M.J. Graves, et al.
Dynamic contrast-enhanced MRI in ovarian cancer: initial experience at 3 tesla in primary and metastatic disease.
Magn Reson Med, 63 (2010), pp. 1044-1049
[4]
I. Thomassin-Naggara, M. Bazot, E. Daraï, P. Callard, J. Thomassin, C.A. Cuenod.
Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
Radiology, 248 (2008), pp. 148-159
[5]
E.A. Sadowski, A.G. Rockall, K.E. Maturen, J.B. Robbins, I. Thomassin-Naggara.
Adnexal lesions: imaging strategies for ultrasound and MR imaging.
Diagn Interv Imaging, 100 (2019), pp. 635-646
[6]
R. Forstner, I. Thomassin-Naggara, T.M. Cunha, K. Kinkel, G. Masselli, R. Kubik-Huch, et al.
ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update.
Eur Radiol, 27 (2017), pp. 2248-2257
[7]
Y.A. Li, J.W. Qiang, F.H. Ma, H.M. Li, S.H. Zhao.
MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
Eur J Radiol, 98 (2018), pp. 136-142
[8]
T.V. Gorodnova, A.P. Sokolenko, E. Kuligina, I.V. Berlev, E.N. Imyanitov.
Principles of clinical management of ovarian cancer.
Chin Clin Oncol, 7 (2018), pp. 56
[9]
A. Guillaume, O. Pirrello.
Preservation of fertility in surgery of benign and borderline malignant ovarian tumors.
J Visc Surg, 155 (2018), pp. S17-21
[10]
H.A. Vargas, T. Barrett, E. Sala.
MRI of ovarian masses.
J Magn Reson Imaging, 37 (2013), pp. 265-281
[11]
I. Thomassin-Naggara, I. Toussaint, N. Perrot, R. Rouzier, C.A. Cuenod, M. Bazot, et al.
Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging.
Radiology, 258 (2011), pp. 793-803
[12]
H.K. Pannu, W. Ma, E.C. Zabor, C.S. Moskowitz, R.R. Barakat, H. Hricak.
Enhancement of ovarian malignancy on clinical contrast enhanced MRI studies.
ISRN Obstet Gynecol, 2013 (2013),
[13]
J. Kaijser, V. Vandecaveye, C.M. Deroose, A. Rockall, I. Thomassin-Naggara, T. Bourne, et al.
Imaging techniques for the pre-surgical diagnosis of adnexal tumours.
Best Pract Res Clin Obstet Gynaecol, 28 (2014), pp. 683-695
[14]
I. Thomassin-Naggara, D. Balvay, A. Rockall, M.F. Carette, M. Ballester, E. Darai, et al.
Added value of assessing adnexal masses with advanced MRI techniques.
Biomed Res Int, 2015 (2015),
[15]
N.M. deSouza, A. Rockall, S. Freeman.
Functional MR imaging in gynecologic cancer.
Magn Reson Imaging Clin N Am, 24 (2016), pp. 205-222
[16]
E.B. Stein, A.P. Wasnik, A.P. Sciallis, A. Kamaya, K.E. Maturen.
MR imaging-pathologic correlation in ovarian cancer.
Magn Reson Imaging Clin N Am, 25 (2017), pp. 545-562
[17]
S.R. Khan, M. Arshad, K. Wallitt, V. Stewart, N. Bharwani, T.D. Barwick.
What’s new in imaging for gynecologic cancer?.
Curr Oncol Rep, 19 (2017), pp. 85
[18]
A. Lindgren, M. Anttila, O. Arponen, S. Rautiainen, M. Könönen, R. Vanninen, et al.
Prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian cancer.
Eur J Radiol, 115 (2019), pp. 66-73
[19]
D. Timmerman, L. Ameye, D. Fischerova, E. Epstein, G.B. Melis, S. Guerriero, et al.
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.
BMJ, 341 (2010), pp. c6839
[20]
World Medical Association.
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.
JAMA, 310 (2013), pp. 2191-2194
[21]
Y.Z. Tang, L. Benardin, T.C. Booth, M.E. Miquel, P. Dilks, A. Sahdev, et al.
Use of an internal reference in semi-quantitative dynamic contrast-enhanced MRI (DCE MRI) of indeterminate adnexal masses.
Br J Radiol, 87 (2014),
[22]
C. Lavini, M.C. de Jonge, M.G. van de Sande, P.P. Tak, A.J. Nederveen, M. Maas.
Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system.
Magn Reson Imaging, 25 (2007), pp. 604-612
[23]
I. Thomassin-Naggara, C.A. Cuenod, E. Darai, C. Marsault, M. Bazot.
Dynamic contrast-enhanced MR imaging of ovarian neoplasms: current status and future perspectives.
Magn Reson Imaging Clin N Am, 16 (2008), pp. 661-672
[24]
X. Li, J.L. Hu, L.M. Zhu, X.H. Sun, H.Q. Sheng, N. Zhai, et al.
The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.
Tumour Biol, 36 (2015), pp. 5515-5522
[25]
S.M. Mansour, S. Saraya, Y. El-Faissal.
Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?.
Br J Radiol, 88 (2015),
[26]
H.M. Li, J.W. Qiang, F.H. Ma, S.H. Zhao.
The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
J Ovarian Res, 10 (2017), pp. 4
[27]
S.J. Yuan, T.K. Qiao, J.W. Qiang, S.Q. Cai, R.K. Li.
The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epitelial ovarian carcinomas.
J Ovarian Res, 10 (2017), pp. 65
[28]
M. Malek, Z. Oghabian, E. Tabibian, M. Rahmani, S.N. Miratashi Yazdi, M.A. Oghabian, et al.
Comparison of Qualitative (Time Intensity Curve Analysis), Semi-Quantitative, and Quantitative Multi-Phase 3T DCEMRI Parameters as Predictors of Malignancy in Adnexal.
Asian Pac J Cancer Prev, 20 (2019), pp. 1603-1611
[29]
V. Singla, K. Dawadi, T. Singh, N. Prabhakar, R. Srinivasan, V. Suri, et al.
Multiparametric MRI evaluation of complex ovarian masses.
Curr Probl Diagn Radiol, (2019),
[30]
P. Mohaghegh, A.G. Rockall.
Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques.
Radiographics, 32 (2012), pp. 1751-1773
[31]
B.G. Hansford, Y. Peng, Y. Jiang, M.W. Vannier, T. Antic, S. Thomas, et al.
Dynamic contrast-enhanced MR imaging curve-type analysis: is it helpful in the differentiation of prostate cancer from healthy peripheral zone?.
Radiology, 275 (2015), pp. 448-457
[32]
L. Li, K. Wang, X. Sun, K. Wang, Y. Sun, G. Zhang, et al.
Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Med Sci Monit, 21 (2015), pp. 376-382
[33]
D. Leithner, G.J. Wengert, T.H. Helbich, S. Thakur, R.E. Ochoa-Albiztegui, E.A. Morris, et al.
Clinical role of breast MRI now and going forward.
Clin Radiol, 73 (2018), pp. 700-714
[34]
P. Dilks, P. Narayanan, R. Reznek, A. Sahdev, A. Rockall.
Can quantitative dynamic contrast-enhanced MRI independently characterize an ovarian mass?.
Eur Radiol, 20 (2010), pp. 2176-2183
[35]
L. Bernardin, P. Dilks, S. Liyanage, M.E. Miquel, A. Sahdev, A. Rockall.
Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation.
Eur Radiol, 22 (2012), pp. 880-890
[36]
A.F. Kazerooni, M. Malek, H. Haghighatkhah, S. Parviz, M. Nabil, L. Torbati, et al.
Semiquantitative dynamic contrast-enhanced MRI for accurate classification of complex adnexal masses.
J Magn Reson Imaging, 45 (2017), pp. 418-427
asdasdasd
Article options
Tools